| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8485361 | Vaccine | 2018 | 9 Pages |
Abstract
Two or 3 doses of MenABCWY showed similar BoC against the panel of invasive US serogroup B isolates and comparable immunogenicity against the antigen-specific test strains, with no safety concerns identified.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jo Anne Welsch, Shelly Senders, Brandon Essink, Thomas Klein, Igor Smolenov, Paola Pedotti, Silvia Barbi, Bikash Verma, Daniela Toneatto,